Compare BIIB & IRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIIB | IRM |
|---|---|---|
| Founded | 1978 | 1951 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.5B | 34.1B |
| IPO Year | 1996 | 1997 |
| Metric | BIIB | IRM |
|---|---|---|
| Price | $249.28 | $110.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 36 | 12 |
| Target Price | ★ $268.26 | $138.73 |
| AVG Volume (30 Days) | 1.1M | ★ 1.4M |
| Earning Date | 10-28-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 3.55% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.66 | 1.23 |
| Revenue | ★ $9,890,600,000.00 | $4,491,531,000.00 |
| Revenue This Year | $6.92 | $16.09 |
| Revenue Next Year | $1.91 | $9.13 |
| P/E Ratio | $94.29 | ★ $90.91 |
| Revenue Growth | 2.22 | ★ 8.30 |
| 52 Week Low | $160.36 | $77.77 |
| 52 Week High | $261.00 | $134.68 |
| Indicator | BIIB | IRM |
|---|---|---|
| Relative Strength Index (RSI) | 54.04 | 45.97 |
| Support Level | $240.00 | $107.58 |
| Resistance Level | $259.89 | $118.53 |
| Average True Range (ATR) | 7.29 | 3.75 |
| MACD | -1.09 | -0.07 |
| Stochastic Oscillator | 43.79 | 47.54 |
Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 40% of total revenue in 2025. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (19% of total in 2025), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).
Iron Mountain Inc is an information management services provider organized and operated as a real estate investment trust. The company offers solutions to its clients to address their information management, digital transformation, information security, data center, and asset lifecycle management (ALM) needs. Its customers come from various industries, including commercial, legal, financial, healthcare, technology, etc. The company has two reportable segments: Global Records and Information Management (Global RIM) and Global Data Center. Maximum revenue is generated from the Global RIM segment, which offers data and records management, secure shredding, consumer storage, and other related services. Geographically, the company generates maximum revenue from the United States.